Dow Down 3.39% Nasdaq Down 4.12%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqCM
5.14 Down 0.13(2.47%) Jun 24, 4:00PM EDT
Prev Close:5.27
Open:4.97
Bid:3.00 x 200
Ask:N/A
1y Target Est:60.00
Beta:4.64242
Earnings Date:Aug 9 - Aug 15 (Est.)
Day's Range:4.97 - 5.36
52wk Range:3.60 - 12.60
Volume:70,645
Avg Vol (3m):87,911
Market Cap:14.86M
P/E (ttm):N/A
EPS (ttm):-4.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCDown 2.47%14.86M
JNJDown 1.49%318.06B
AZNDown 4.88%70.49B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :N/A
Quarterly EPS Est (Mar-16) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs for the treatment of cancer and other diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback